Clinical Trials Browser

Phase 2 × Enrolling by invitation × Cognitive Dysfunction × Clear all

NCT06723015 2025-11-18

Tau PET Outcomes With Anti-amyloid Immunotherapies

Phase 2 Enrolling by invitation

Alzheimer Disease, Dementia, Lymphoma, Follicular, Cognitive Dysfunction